Back
Enanta Pharmaceuticals Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
21
ENTA
Enanta Pharmaceuticals
Last Price:
$5.36
Seasonality Move:
-1.62%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENTA is experiencing slight selling pressure.
Enanta Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.26 | Sell |
| 20-day SMA: | 5.46 | Sell |
| 50-day SMA: | 5.71 | Sell |
| 200-day SMA: | 8.61 | Sell |
| 8-day EMA: | 5.34 | Sell |
| 20-day EMA: | 5.27 | Sell |
| 50-day EMA: | 4.24 | Buy |
| 200-day EMA: | 1.74 | Buy |
Enanta Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 44.42 | Sell |
| Chaikin Money Flow: | -7264 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.86 - 5.76) | Sell |
| Bollinger Bands (100): | (4.88 - 6.8) | Sell |
Enanta Pharmaceuticals Technical Analysis
| May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enanta Pharmaceuticals Stock
Is Enanta Pharmaceuticals Stock a Buy?
-
Enanta Pharmaceuticals share price is 5.18 while ENTA 8-day simple moving average is 5.26, which is a Sell signal.
-
The stock price of ENTA is 5.18 while Enanta Pharmaceuticals 20-day SMA is 5.46, which makes it a Sell.
-
Enanta Pharmaceuticals 50-day simple moving average is 5.71 while ENTA share price is 5.18, making it a Sell technically.
-
ENTA stock price is 5.18 and Enanta Pharmaceuticals 200-day simple moving average is 8.61, creating a Sell signal.
ENTA Technical Analysis vs Fundamental Analysis
Sell
21
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy or a Sell?
-
Enanta Pharmaceuticals stock is rated a SellThe current Enanta Pharmaceuticals [ENTA] share price is $5.18. The Score for ENTA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Enanta Pharmaceuticals Stock Info
Market Cap:
110.5M
Price in USD:
5.18
Share Volume:
116.2K
Enanta Pharmaceuticals 52-Week Range
52-Week High:
17.24
52-Week Low:
4.09
Sell
21
Enanta Pharmaceuticals (ENTA)
is a Sell
Enanta Pharmaceuticals Share Price Forecast
-
What is the Enanta Pharmaceuticals stock price today?The Enanta Pharmaceuticals stock price is 5.18 USD today.
-
Will ENTA stock go up or go down?Enanta Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Enanta Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enanta Pharmaceuticals is overvalued.
Is Enanta Pharmaceuticals Stock a Buy?
-
Enanta Pharmaceuticals share price is 5.18 while ENTA 8-day exponential moving average is 5.34, which is a Sell signal.
-
The stock price of ENTA is 5.18 while Enanta Pharmaceuticals 20-day EMA is 5.27, which makes it a Sell.
-
Enanta Pharmaceuticals 50-day exponential moving average is 4.24 while ENTA share price is 5.18, making it a Buy technically.
-
ENTA stock price is 5.18 and Enanta Pharmaceuticals 200-day simple moving average is 1.74, creating a Buy signal.
Fundamental Analysis of Enanta Pharmaceuticals
Is Enanta Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.05 per share, an increase this year of $1.30 per share, and a decrease next year of $0.40 per share.
Technical Analysis of Enanta Pharmaceuticals
Should I short Enanta Pharmaceuticals stock?
-
ENTA Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting Enanta Pharmaceuticals is a Buy
-
Enanta Pharmaceuticals Relative Strength Index (RSI) is 44.42, which suggest Enanta Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Enanta Pharmaceuticals is (4.86 - 5.76), which suggest Enanta Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Enanta Pharmaceuticals is (4.88 - 6.8), which suggest Enanta Pharmaceuticals is a Sell
* Enanta Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.